Diaceutics PLC
DIUXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $92,300 | $90,732 | $77,914 | $83,721 |
| - Cash | $12,744 | $16,667 | $19,841 | $19,675 |
| + Debt | $1,060 | $1,205 | $1,329 | $1,561 |
| Enterprise Value | $80,616 | $75,270 | $59,402 | $65,607 |
| Revenue | $32,158 | $23,699 | $19,504 | $13,943 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Gross Profit | $28,270 | $19,706 | $14,037 | $10,566 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| EBITDA | $2,773 | $2,401 | $3,608 | $2,112 |
| % Margin | 8.6% | 10.1% | 18.5% | 15.1% |
| Net Income | -$1,703 | -$1,746 | $724 | $561 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| % Growth | 2.4% | -346.4% | 27.3% | – |
| Operating Cash Flow | $651 | $1,311 | $5,148 | $570 |
| Capital Expenditures | -$4,632 | -$4,855 | -$4,870 | -$5,601 |
| Free Cash Flow | -$3,981 | -$3,544 | $278 | -$5,031 |